A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy
Thu Le Trinh(University of Florida), Chen Liu(Novartis (Switzerland))
Cited by 82
Related Papers
Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling
|Clinical Cancer Research|2020|161
OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma
|Laboratory Investigation|2012|83
Survivin Inhibition Is Critical for Bcl-2 Inhibitor-Induced Apoptosis in Hepatocellular Carcinoma Cells
|PLoS ONE|2011|48
AMPK blunts chronic heart failure by inhibiting autophagy
|Bioscience Reports|2018|46